Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study

Summary In this national cohort study, the patients with acromegaly had significantly higher risks of clinical vertebral (HR 2.09 [1.58–2.78]) and hip (HR 2.52 [1.61–3.95]) fractures than the controls. The increased fracture risk in patients with acromegaly was time-dependent and was observed even during the early period of follow-up. Purpose Acromegaly is characterized by the overproduction of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), both play important roles in regulating bone metabolism. We investigated the risk of vertebral and hip fractures in patients with acromegaly compared to age- and sex-matched controls. Methods This nationwide population-based cohort study included 1,777 patients with acromegaly aged 40 years or older in 2006–2016 and 8,885 age- and sex-matched controls. A Cox proportional hazards model was used to estimate the adjusted hazard ratio (HR) [95% confidence interval]. Results The mean age was 54.3 years and 58.9% were female. For approximately 8.5 years of follow-up, the patients with acromegaly had significantly higher risks of clinical vertebral (HR 2.09 [1.58–2.78]) and hip (HR 2.52 [1.61–3.95]) fractures than the controls in the multivariate analyses. There were significant differences in the risks of clinical vertebral ( P < 0.0001) and hip ( P < 0.0001) fractures between the patients with acromegaly and the controls in the Kaplan–Meier survival analysis. The multivariable-adjusted HRs for clinical vertebral fractures comparing the patients with acromegaly with controls during and excluding the first 7 years of observation were 1.69 [1.15–2.49] and 2.70 [1.75–4.17], respectively. The HRs for hip fractures during and excluding the first 7 years of observation were 2.29 [1.25–4.18] and 3.36 [1.63–6.92], respectively. Conclusions The patients with acromegaly had a higher risk of hip fractures as well as clinical vertebral fractures than the controls. The increased fracture risk in patients with acromegaly was time-dependent and was observed even during the early period of follow-up.